Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR) — Form 8-K: Current report
About this filing
Citius Pharmaceuticals, Inc. (CTXR) filed an 8-K on Aug 21, 2026 reporting a delisting or listing-rule notice or listing transfer (Item 3.01).
Key facts
- Item 3.01 · Delisting or listing-rule notice or listing transfer
More CTXR filings
- 8-K
Filed Oct 26, 2026
- 10-Q
Filed Aug 14, 2026
- 8-K
Filed Aug 14, 2026
- SC 13G/A
Filed Aug 14, 2026
- UPLOAD
Filed Aug 10, 2026
- 8-K
Filed Aug 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.